Cargando…
SARS-CoV-2 Vaccine Development: Current Status
In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic and its attendant morbidity and mortality, safe and efficacious vaccines are needed that induce protective and long-lived immune responses. More than 120 vaccine candidates worldwide are in various preclinical and phase 1 t...
Autores principales: | Poland, Gregory A., Ovsyannikova, Inna G., Crooke, Stephen N., Kennedy, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392072/ https://www.ncbi.nlm.nih.gov/pubmed/33012348 http://dx.doi.org/10.1016/j.mayocp.2020.07.021 |
Ejemplares similares
-
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
por: Crooke, Stephen N., et al.
Publicado: (2020) -
Zika Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2019) -
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
por: Poland, Gregory A, et al.
Publicado: (2020) -
Immunosenescence and human vaccine immune responses
por: Crooke, Stephen N., et al.
Publicado: (2019) -
Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA
por: Quach, Huy Quang, et al.
Publicado: (2022)